ARCHIVES

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

This article is from The Cancer Letter archive.

Vol. 26 No. 19 | May 12, 2000

Download PDF Visit The Full Archive

Related Articles

Radiation Table Recommendations Completed

July 22, 1983

NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”

May 7, 1993

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

DCPC Advisors OK Expansion Of Science Enrichment Program, Other Concepts

November 1, 1991

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

Kansas Cancer Institute gets $15 million pledge, is renamed, and hires a new director in effort to win NCI center grant.

April 16, 2004